Ulmer’s Life Sciences Industry Group regularly assists national and global corporations with their most urgent legal issues, from drug patenting to high-stakes litigation. Our team advises makers of pharmaceuticals, medical devices, and biotechnologies on a range of issues, including regulatory matters, transactions, and the management of IP portfolios.
Clients regularly turn to Ulmer for our nationally recognized practice defending pharmaceutical companies and others in high exposure class action litigation. We have represented clients in high-profile product liability litigation involving, for instance, pain medications, hormone replacement therapies, ADHD medications, gastrointestinal medications, antidepressants, contraceptives, pelvic mesh, and weight-loss medications. We frequently serve as national counsel in such large-scale litigation efforts.
Our team members routinely handle novel issues that are shaping the legal landscape in which pharmaceutical companies, medical device makers, and other clients operate. To that task, we bring our legal experience, along with first-hand industry knowledge. Our team members have advanced degrees and industry experience in pharmacology, chemistry, biochemistry, medical technology, and engineering. Our team members also have experience with human clinical trials and have published in peer-reviewed scientific journals.